Clinical trials: Tight control in early RA pays off in the long run.
other
Where this comes from
- Record sourced from PubMed, PMID 21037562.
- Also identified by DOI 10.1038/nrrheum.2010.174.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Clinical trials demonstrate that intensive treatment of early rheumatoid arthritis with a combination of DMARDs improves short-term outcomes. an extension study from a pivotal trial has now shown that such intensive early therapy can achieve a reduction in the rate of erosive progression over a period of 11 years.
Medical subject headings
- Antirheumatic Agents
- Arthritis, Rheumatoid